Starling Medical, a Huston, Texas-based healthcare startup announced that it has closed on $3.4 million in seed funding, led by Rebel Fund with the participation of Y Combinator, Innospark Ventures, AI Basis, Capital Factory, Coho Deeptech, Magic Fund, Rogers Family Office, Hendricks Family Office, ReMy Ventures, Centauri Fund, Praxis SCI Institute, Gaingels and a group of angel investors.

The funds will be used to establish an engineering team, develop the device and software, and hire nurses and support personnel. Nurses review the urinalysis results and file for reimbursement for remote patient monitoring. The firm now has 10 employees.

The Houston-based company hopes to reduce hospitalizations caused by chronic conditions such as urinary tract infections, diabetes, and kidney disease, and will eventually expand into dozens of other health conditions detectable through urine testing, such as preeclampsia during pregnancy.